Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset
During the past two decades, an increasing number of patients with very-late-onset myasthenia gravis (v-LOMG) with an onset age of 65 years or older have been identified. However, few studies explore the predictors of secondary generalization in patients with v-LOMG with pure ocular onset. In this r...
Main Authors: | Sijia Zhao, Xu Yan, Jiaqi Ding, Kaixi Ren, Shuyu Sun, Jiarui Lu, Chao Zhang, Kai Zhang, Zhuyi Li, Jun Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.857402/full |
Similar Items
-
Late-onset myasthenia gravis: Is it a different clinical entity?
by: Hulya Tireli, et al.
Published: (2021-01-01) -
A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis
by: Yang TT, et al.
Published: (2023-12-01) -
Clinical characteristics of late-onset myasthenia gravis
by: Chenjing Sun, et al.
Published: (2024-04-01) -
Recent Advances in Post-operatively New Onset Myasthenia Gravis in Thymoma Patients
by: LIU Haoran, et al.
Published: (2023-10-01) -
Late-onset myasthenia gravis is predisposed to become generalized in the elderly
by: Waka Sakai, et al.
Published: (2016-03-01)